Display options
Share it on

Int J Endocrinol. 2010;2010:178671. doi: 10.1155/2010/178671. Epub 2010 Dec 15.

Intraoperative PTH Assay during Minimally Invasive Parathyroidectomy May Be Helpful in the Detection of Double Adenomas and May Minimise the Risk of Recurrent Surgery.

International journal of endocrinology

E Ypsilantis, H Charfare, W S Wassif

Affiliations

  1. Princess Royal University Hospital, Farnborough Common, London BR6 8ND, UK.

PMID: 21197437 PMCID: PMC3010640 DOI: 10.1155/2010/178671

Abstract

Background. Minimally invasive parathyroidectomy (MIP) is increasingly replacing the traditional bilateral neck exploration in the treatment of primary hyperparathyroidism (PHP). Intraoperative PTH (IOPTH) measurement has recently been introduced as a useful adjunct in confirming successful excision of abnormal parathyroid gland. Aims. We evaluate the safety, efficacy, and clinical usefulness of IOPTH measurement during MIP in a district general hospital. Methods. Retrospective review of eleven consecutive patients with PHP who underwent MIP with IOPTH, following preoperative assessment with ultrasound and sestamibi scans. Results. All patients had successful removal of the abnormal parathyroid gland. The concordance rate between ultrasound and sestamibi scan in localising the parathyroid adenoma was 82%. IOPTH measurement confirmed the removal of adenoma in all cases and, in one case, led to identification of a second adenoma, not localised preoperatively. The median hospital stay was 2 days (range 1-7 days). All patients remained normocalcaemic after a median of 6 months (range 1-10 months). Conclusions. Minimally invasive parathyroidectomy is a feasible, safe, and effective method for treatment of PHP. The use of IOPTH monitoring potentially offers increased sensitivity in detecting multiglandular disease, can minimise the need and risk associated with recurrent operations, and may facilitate cost-effective minimally invasive surgery.

References

  1. Arch Surg. 2002 Aug;137(8):896-9; discussion 899-900 - PubMed
  2. Age Ageing. 2003 Nov;32(6):571-8 - PubMed
  3. Surgery. 2005 Dec;138(6):1130-5; discussion 1135-6 - PubMed
  4. World J Surg. 2002 Aug;26(8):926-30 - PubMed
  5. Clin Endocrinol (Oxf). 1999 Feb;50(2):191-6 - PubMed
  6. J Clin Endocrinol Metab. 2002 Mar;87(3):1024-9 - PubMed
  7. Surg Clin North Am. 2004 Jun;84(3):717-34 - PubMed
  8. Br J Biomed Sci. 2003;60(1):35-6 - PubMed
  9. J Clin Endocrinol Metab. 1993 Dec;77(6):1485-9 - PubMed
  10. Ann Surg. 2005 Sep;242(3):375-80; discussion 380-3 - PubMed
  11. Ann R Coll Surg Engl. 1992 Jan;74(1):19-22 - PubMed
  12. Arch Surg. 2005 Feb;140(2):146-9; discussion 150 - PubMed
  13. Ann Surg. 2002 Nov;236(5):543-51 - PubMed
  14. Ann Surg. 2009 Mar;249(3):469-72 - PubMed
  15. Surgery. 2007 Dec;142(6):930-5; discussion 930-5 - PubMed
  16. Am J Surg. 1991 Oct;162(4):299-302 - PubMed
  17. Clin Chem. 2002 Oct;48(10):1731-8 - PubMed
  18. Laryngoscope. 2005 Jun;115(6):1128-31 - PubMed
  19. Surgery. 1997 Mar;121(3):287-94 - PubMed
  20. Br J Surg. 1996 Jul;83(7):989-91 - PubMed
  21. Am J Surg. 2001 Jul;182(1):15-9 - PubMed
  22. Surgery. 2001 Dec;130(6):963-70 - PubMed
  23. Arch Surg. 2005 Apr;140(4):371-3 - PubMed
  24. J Am Coll Surg. 2003 Apr;196(4):535-40 - PubMed
  25. World J Surg. 2010 Mar;34(3):538-43 - PubMed
  26. Eur J Nucl Med. 2001 Jun;28(6):736-42 - PubMed
  27. Arch Surg. 1989 Mar;124(3):331-5 - PubMed
  28. BMJ. 2004 Apr 10;328(7444):849-50 - PubMed
  29. Clin Chim Acta. 1971 Jan;31(1):87-96 - PubMed
  30. Nucl Med Commun. 1989 Nov;10(11):791-4 - PubMed
  31. Surg Clin North Am. 2000 Oct;80(5):1399-426 - PubMed

Publication Types